ResearchPool

ResearchPool


ResearchPool, the leading open platform for #investmentresearch. 1.2M reports for public reading and tools to enhance professional investors #valuingknowledge

7989 followers  •  4359 follow  •    •   https://t.co/2iuyUSt5wg

$EPZM #Epizyme  Inc ... Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 3: | #equity  #stocks 

tweet picture

ING - G10 FX Week Ahead: Gimme guidance: With central bank meetings in the eurozone, Japan and Canada unlikely to trigger big currency moves, markets will keep a close eye on the guidance provided by US banks as the earning season kicks in. Elsewhere, EU…

$BON #Bonheur  ASA Bonheur - Q2 was likely soft – but that is well known: Low electricity prices and paused cruise operations Our Q2e EBITDA NOK 105m is above FactSet of NOK 62m BUY rating and TP of NOK 275 reiterated #equity  #stocks 

tweet picture

Loading
Loading

$KEFI #Kefi  Minerals KEFI Minerals - Tulu Kapi project started and financings improved: Since our last note, KEFI Minerals has achieved a number of key development milestones and prepared the TKGM consortium and its own balance sheet for:… #equity  #stocks 

tweet picture

$ONCO #Oncopeptides  AB Oncopeptides (Buy, TP: SEK247.00) - New tricks for the pony: Oncopeptides hosted a CMD in New York on Friday. The key take-aways were: 1) the company is very satisfied with how all the Ygalo® trials are developing; 2) OCEAN data…

tweet picture

$NXO #Nexoptic  Technology Corp NexOptic Technology Corp. (TSXV: NXO / OTCQB: NXOPF / FRA: E3O1) Technology Company Looking to Disrupt the AI and Lens Market – Introductory Note: Fundamental Research Corp has issued a report entitled… #equity  #stocks 

$IPH #Innate  Pharma SA INNATE PHARMA - BUY | EUR13.8 (+130%) Monalizumab in IO-pre-treated SCCHN patients confirms promises - Contact: ASCO abstract confirms activity of mona-cetux in advanced SCCHN Advoralimab should be seen as offering… #equity  #stocks 

tweet picture

$AMD #Advanced  Micro Devices Inc. ... 2Q20 Preview - Fundamentals Should Boost SIMOs Outlook: | #equity  #stocks 

$ALTHX #Theranexus  SA THERANEXUS: In a strong position to sign a deal for THN-102 before year’s end | CORPORATE | EUR20 vs. EUR23 (+122%): THERANEXUS - CORPORATE | EUR20 vs. EUR23 (+122%) In a strong position to sign a deal for THN-102… #equity  #stocks 

tweet picture

$IMMU #Immunicum  AB Immunicum - Full analysis of MERECA top-line results: The last several weeks have been volatile for Immunicum and illustrate how complicated immunotherapy efficacy trials can be. On 29 August 2019, the company released… #equity  #stocks 

tweet picture

$A1XAEB #Quantum  Genomics S.A.S. INVEST SECURITIES - QUANTUM GENOMICS : Looking Beyond Firibastats rHTN program - BUY, TP 9,0€: |

tweet picture

Loading
Loading